OLR1 and endothelial dysfunction: Moreover, the activation of LOX-1 modulates several pathological processes, especially proatherogenic pathways, resulting in endothelial dysfunction, SMC migration, monocyte recruitment, foam-cell formation, and platelet activation [98].